IL6 and cancer: Several studies have shown that EGCG inhibits the escalation of IL‐6 level in liver injury and exhibits a protective effect in cancer via the JAK/STAT3 pathway (Lee et al., 2004; Liu, Zhang, Jiang, Guo, & Zheng, 2014).